<DOC>
	<DOC>NCT00150293</DOC>
	<brief_summary>To determine long-term safety and efficacy of pregabalin in patients with partial seizures.</brief_summary>
	<brief_title>Evaluation of Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Must have met the inclusion criteria for preceding doubleblind study Have received doubleblind study medication and wish to receive openlabel pregabalin. Cannot be pregnant or considering becoming pregnant during the course of the study. Cannot be receiving any concomitant medication that could alter the effectiveness of the pregabalin response or affect seizure frequency.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>